HOX THERAPEUTICS
HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology Department to develop new therapeutics for cancer, based on the role of HOX genes in cancer.
HOX THERAPEUTICS
Industry:
Biotechnology Health Care
Address:
Guildford, Surrey, United Kingdom
Country:
United Kingdom
Website Url:
http://www.hoxtherapeutics.com
Status:
Active
Total Funding:
1.85 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Similar Organizations
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Tangram Partners Limited
Tangram Partners Limited investment in Seed Round - Hox Therapeutics
Tangram Partners Limited
Tangram Partners Limited investment in Seed Round - Hox Therapeutics
Tangram Partners Limited
Tangram Partners Limited investment in Seed Round - Hox Therapeutics
Official Site Inspections
http://www.hoxtherapeutics.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K
- Host name: 185-151-30-200.ptr4.stackcp.net
- IP address: 185.151.30.200
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Hox Therapeutics"
HOX Therapeutics
Designing new therapies for cancer. Hox is a preclinical-stage biotechnology company focused on the discovery and development of novel, targeted medicines for the treatment of cancer.See details»
About Hox - HOX Therapeutics
About Hox. Co-founded by Professors Hardev Pandha and Richard Morgan, Hox is a spin-out from the University of Surrey. We are focused on developing innovative, first-in-class and highly targeted treatments for cancerSee details»
Team – HOX Therapeutics
Team. Hox Therapeutics has assembled a high-performing, world-class leadership Executive Team to provide strategic and operational oversight. Click on each image for biographical information.See details»
Hox Therapeutics - Crunchbase Company Profile
HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology Department to develop new therapeutics for cancer, based on the role of HOX …See details»
HOX Therapeutics Ltd | LinkedIn
HOX Therapeutics Ltd | 177 followers on LinkedIn. HOX Therapeutics is focused on developing novel treatments for cancer. Our lead programme is a dual inhibitor of the androgen receptor …See details»
Hox Therapeutics Ltd. - Life-Sciences-Europe.com
Https://www.hoxtherapeutics.com HOX Therapeutics is developing innovative, first-in-class and highly targeted cancer therapies. Its scientific approach is based on the over expression and …See details»
Hox Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials
Explore Hox Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 3 news, Disease Domain:Nervous System Diseases, Neoplasms, Technology ...See details»
Hox Therapeutics and Vernalis announce a drug discovery …
For more information, please visit www.hoxtherapeutics.com. About Vernalis. Vernalis is a world leader in fragment and structure-based drug discovery with a record of progressing targets …See details»
Hox Therapeutics and Vernalis announce a drug discovery
Feb 19, 2024 For more information, please visit www.hoxtherapeutics.com About Vernalis Vernalis is a world leader in fragment and structure-based drug discovery with a record of …See details»
Hox Therapeutics and Vernalis announce a drug discovery …
Feb 20, 2024 For more information, please visit www.hoxtherapeutics.com About Vernalis Vernalis is a world leader in fragment and structure-based drug discovery with a record of …See details»
Hox Therapeutics and Vernalis announce a drug discovery …
Feb 20, 2024 Hox Therapeutics Ltd ("Hox") a private biotechnology company developing highly targeted cancer therapies and Vernalis (R&D) Ltd ("Vernalis"), a fully owned subsidiary of …See details»
HOX Therapeutics - Company Profile - Tracxn
Oct 20, 2024 HOX Therapeutics - Developer of therapies for treating cancer targeting HOX proteins. Raised a total funding of $924K over 3 rounds. Founded by Hardev Pandha and …See details»
HOX Therapeutics - VentureRadar
HOX Therapeutics VentureRadar profile. Find out more about HOX Therapeutics, DNA, RNA and Peptide Therapies.See details»
Targets – HOX Therapeutics
Targets. Our scientific approach is based on targeting two different tumour-driving mechanisms. Hox genes A set of genes that play key roles in defining the identity of cells and tissues in …See details»
Scientific publications – HOX Therapeutics
Scientific Publications Hox genes. Morgan R & Panda HS. PBX3 in Cancer. Cancers 2020, 12: 431. doi: 10.3390/cancers12020431. Idaikkadar P, Morgan R, & Michael A. HOX Genes in …See details»
Hox Therapeutics - Contacts, Employees, Board Members
HOX Therapeutics Ltd is a spin-off from the University of Surrey Oncology DepartmentSee details»
Hox Therapeutics And Vernalis Announce A Drug Discovery …
Feb 20, 2024 For more information, please visit www.hoxtherapeutics.com. About Vernalis Vernalis is a world leader in fragment and structure-based drug discovery with a record of …See details»
HOX THERAPEUTICS LIMITED - Companies House
HOX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Hox Therapeutics and Vernalis announce a drug discovery …
Feb 21, 2024 For more information, please visit www.hoxtherapeutics.com . About Vernalis. Vernalis is a world leader in fragment and structure-based drug discovery with a record of …See details»
Fiona McLaughlin – HOX Therapeutics
Dr Fiona McLaughlin Non-Executive Director. Dr Fiona McLaughlin is a highly experienced oncology drug developer, bringing over 25 years of experience in research and translational …See details»